Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$677M |
| 2 |
Tesla
TSLA
|
+$374M |
| 3 |
Constellation Brands
STZ
|
+$357M |
| 4 |
NVIDIA
NVDA
|
+$292M |
| 5 |
Meta Platforms (Facebook)
META
|
+$264M |
Top Sells
| 1 |
Netflix
NFLX
|
+$892M |
| 2 |
Charter Communications
CHTR
|
+$838M |
| 3 |
AbbVie
ABBV
|
+$553M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$488M |
| 5 |
FedEx
FDX
|
+$418M |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Consumer Discretionary | 17.73% |
| 3 | Financials | 13.26% |
| 4 | Healthcare | 11.95% |
| 5 | Communication Services | 11.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Teradata
TDC
$2.01B
| $33.6M | 0.03% |
836,618
-3,899
| -0.5% | -$157K |
|
327
Qualcomm
QCOM
$173B
| $33.4M | 0.03% |
594,677
-971,268
| -62% | -$54.5M |
|
|
MCRN
328
DELISTED
Milacron Holdings Corp.
MCRN
| $33.1M | 0.03% |
1,747,695
+56,319
| +3% | +$1.07M |
|
329
FibroGen
FGEN
$45.1M
| $32.9M | 0.03% |
21,054
+8,052
| +62% | +$12.6M |
|
|
DBVT
330
DBV Technologies
DBVT
$245M
| $32.9M | 0.03% |
170,773
+24,752
| +17% | +$4.77M |
|
331
MGM Resorts International
MGM
$9.85B
| $32.1M | 0.03% |
1,106,950
-584,652
| -35% | -$17M |
|
332
Plains All American Pipeline
PAA
$12.1B
| $31.6M | 0.03% |
1,336,483
+213,514
| +19% | +$5.05M |
|
|
CLVS
333
DELISTED
Clovis Oncology, Inc.
CLVS
| $31.4M | 0.03% |
690,563
-7,013
| -1% | -$319K |
|
334
Byline Bancorp
BY
$1.35B
| $31.2M | 0.03% |
1,396,190
+173,074
| +14% | +$3.87M |
|
335
Enerpac Tool Group
EPAC
$2.29B
| $31.1M | 0.03% |
1,059,713
+146,290
| +16% | +$4.29M |
|
|
RVNC
336
DELISTED
Revance Therapeutics, Inc.
RVNC
| $31.1M | 0.03% |
1,131,960
-351,077
| -24% | -$9.64M |
|
337
Take-Two Interactive
TTWO
$45.9B
| $30.8M | 0.03% |
+260,578
| New | +$30.8M |
|
338
Royal Caribbean
RCL
$95.4B
| $30.7M | 0.03% |
296,585
-10,869
| -4% | -$1.13M |
|
|
EVOP
339
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $30.6M | 0.03% |
+1,485,490
| New | +$30.6M |
|
340
BlackBerry
BB
$2.29B
| $30.4M | 0.03% |
3,150,527
+1,105,890
| +54% | +$10.7M |
|
|
MRTX
341
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $30.3M | 0.03% |
614,719
+86,323
| +16% | +$4.26M |
|
342
Ameris Bancorp
ABCB
$5.08B
| $29.9M | 0.03% |
560,800
+6,928
| +1% | +$370K |
|
|
ZEN
343
DELISTED
ZENDESK INC
ZEN
| $29.8M | 0.03% |
547,257
-114,572
| -17% | -$6.24M |
|
344
Wendy's
WEN
$1.92B
| $29.7M | 0.03% |
1,728,798
-189,879
| -10% | -$3.26M |
|
|
EPZM
345
DELISTED
Epizyme, Inc
EPZM
| $29.6M | 0.03% |
2,184,788
+36,762
| +2% | +$498K |
|
346
Travere Therapeutics
TVTX
$1.89B
| $29.2M | 0.03% |
1,070,327
+14,166
| +1% | +$386K |
|
347
Olin
OLN
$2.87B
| $28.1M | 0.03% |
978,965
-238,588
| -20% | -$6.85M |
|
348
Spotify
SPOT
$148B
| $27.8M | 0.03% |
+165,408
| New | +$27.8M |
|
349
Glaukos
GKOS
$5.27B
| $27.6M | 0.03% |
678,096
+75,990
| +13% | +$3.09M |
|
350
argenx
ARGX
$47B
| $27.5M | 0.03% |
332,013
+5,276
| +2% | +$437K |
|